Acute benefits of Wasabi tablets on cognition and neural activity

UMIN ID: UMIN000036461

Registered date:10/04/2019

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Young Healthy adults
• Date of first enrollment: 2019/05/01
• Target sample size: 40
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

Intake a Wasabi tablet once
Intake a placebo table once

Outcome(s)

• Primary Outcome: Brain activity during cognitive tasks
• Secondary Outcome: STAI:State Trait Anxiety Inventory WHO-5:WHO Five well-being index GHQ12:General Health Questionnaire 12 CES-D:center for epidemiologic studies depression scale Sleep scale brief-type self-administered diet history questionnaire daily activities Ten Item Personality Inventory Effortful control scale Profile of Mood States2 TDMS-ST:Two dimensional Mood Scale-Short Term VAS for tastiness of Wasabi tablet

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: 30years-old
• Gender: Male and Female
• Exclude criteria: Who have a medical history of mental disorder or neurological disorder take medical drug which may affect the brain and cognition have a visual disability Allergy for food is participating in other intervention studies

Related Information

• Primary Sponsor: Tohoku Univerisity
• Source(s) of Monetary Support: Kinjirushi